Company News
Novo Nordisk Up 2.1% After Wegovy Tablet
Novo Nordisk shares rose 2.1% on Thursday following MHRA approval of a daily Wegovy tablet for weight loss.
The tablet, the first GLP‑1 pill approved in the UK, is for adults with BMI ≥30 or 27‑30 wit
